Home
overview

Prior to the approval of new drugs, substantial evidence of efficacy is required and safety brought through clinical trials. A massive decline in success rates in Phase II/III of clinical trials has resulted in only 1 in 10 drugs successfully passing  through these trials in the US.

With increasing pressure to bring drugs quickly into the market and reduce the cost of drug development, the paradigms of drug dosage studies in phase II trials and the overall adaptive framework of clinical trials are being increasingly challenged. Thus, strategies such as “Seamless Adaptive Designs” and “Group –Sequential Adaptive Designs” are particular areas that have received a great deal of attention in helping to improve the efficiency of drug development.

This conference will review the drug development process and provide a detailed discussion of how adaptive designs are changing the development process. The main focus of the presentation will be to explore the role of adaptive sample sizing; in particular, why it is important to consider the need to reassess sample sizes during the course of a trial. It is designed for those looking to network and gain the latest knowledge from the academics, industry leaders and regulators.

 

Now entering our 7th year in hosting Adaptive Designs in Clinical Trials, we continue to draw high level international speakers whom are pushing foward with Adaptive Designs in Clinical Trials.

This conference will have a strong international focus, featuring speakers from Europe and USA whom will share their research, challenges and discuss future plans and open new avenues to promote Adaptive Designs.

Some of our key highlights will include: 

  • Novel Responsive-Adaptive Designs that can optimise dose-finding strategies
  •  Multi-armed Bayesian bandit models,
  • Seamless adaptive designs
  • Adapting real world data.

The conference will also appeal to those looking to understand regulatory submissions across the international landscape, including parallels and discrepancies between the FDA, EMA and PDMA methods of regulation, not to mention MAPPs and Adaptive Licensing!

Why not gain an insight  into what may often be overlooked as the implimentation of adaptive protocols in emerging markets from the CEE region?
 

  • Listen to talks on new predictive biomarker designs used to separate sensitivity levels in patients
  • Enhance your understanding of Bayesian survival models and how Bayesian belief networks can leverage operational risks in clinical trials
  • Join the discussion on the recognised need of real world evidence to enhance the flexibility of adaptive clinical trials and improve patient care
  • Explore the novel applications of adaptive designs in early and late phase clinical trials
  • Learn novel design strategies in Bio-marker driven adaptive designs from Multi Arms Multi Stage (MAMS) trials to adapting Group Sequential Enrichment Designs and Combination Tests: How may these establish appropriate cut off points to distinguish sensitive and insentsitive patients? 

Join the panel to discuss latest news stories and ways to implement Adaptive tools to address critical unmet clinical needs such as: 

  • Ebola; Alzheimer's disease; Oncology

 

Clinical trial managers & associates
Biostatisticians
Directors of business developement
Data managers
Senior statisticians
Professors of statistics
Directors of Clinical trials
Medical doctors
PhD students
Clinical scientists

Featured companies include:

Abbott GmbH & Co KG; Aptiv Solutions ; Astellas Pharma Europe; AstraZeneca; Berry Consulting; Boehringer Ingelheim Pharma GmbH & Co. KG; Boehringer-Ingelheim; Chalmers University Of Technology; Cmed; Cytel Pharmaceutical Research; EBD Consulting ; F. Hoffmann-La Roche Ltd; Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten; Fyntoma Consultancy; GlaxoSmithKline; GSK; Hoffman La Roche; ICNARC; Imperial College London; KING ABDULAZIZ MEDICAL CITY; LSE; Medidata; Merck Serono International S.A.; Montreal Heart Institute Coordinating Center; Newcastle University; Novartis International AG; Oxford University; PA Consulting Group; PPD; Queen Mary, University of London; RPS Research France; Sankyo Co Ltd; Sanofi Aventis; Sanofi-Aventis; Sanofi-Aventis R& Tessella Support Services; University Of Bath; Vanderbilt University Medical Center; Vertex Pharmaceuticals Inc; Vifor Pharma.

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Graham Clarke

Graham Clarke, Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles
View Bio

9:10 OPENING ADDRESS: Enhancing study design and biomarker read-outs in early clinical development

Graham Clarke

Graham Clarke, Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles
View Bio

 

  •  Design strategies in early clinical phase – Phase I/II drug development process
  •  Implementation of biomarkers and validating end points – design protocols, optimisation and patient strategies in precision or personalised medicine. 
  • Highlight the main challenges to ongoing developments and global efforts, including biomarker collection and data loss issues
  • 9:50 Succeeding in Bayesian Adaptive Design

    Sophie Carr

    Sophie Carr, MD and Principal Analyst, Bays Consulting Ltd

  • Understand the key components of Bayesian statistics to enhance decision- making
  • Predictive classifiers in the Bayesian belief networks
  • Bayesian survival models and predicting time events in clinical trials
  • Operational-risk management: A Bayesian approach to modelling risk and uncertainties
  • 10:30 Morning Coffee

    11:00 Group Sequential Enrichment Design incorporating subgroup selection – Application to the optimization of the cut-off for a continuous predictive biomarker with time-to-event endpoints

    Emilie Gerard

    Emilie Gerard, Biostatistician provider, Hays Life Sciences

     

  • Adapting the Group Sequential Enrichment Design (GSED) methodology & the Combination Tests (CT) methodology to address important problems
  •  Introducing new performance indicators to assess the soundness of the subpopulation selection
  • Exploring the operating characteristics of GSED and CT designs via simulations under a wide range of scenarios
  • 11:40 Real world patient data in adaptive clinical designs

    Mohammad Al-Ubaydli

    Mohammad Al-Ubaydli, CEO, Patients Know Best
    View Bio

     

  •   How real time data monitoring gives higher quality, lower costs and happier patients
  •  How real world data can improve adaptive trial design
  • Structure and regulatory challenges and requirements for best clinical practices set out by the European Commission
  •  Case studies related to current research and the organization.
  • 12:20 Networking Lunch

    13:30 Afternoon Chairman's Opening Remarks

    Tamas L. Paal

    Tamas L. Paal, Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy
    View Bio

    13:40 KEYNOTE ADDRESS: Outlook of clinical trials in the CEE region

     

  • Implementation of adaptive protocols
  • Nature of regulatory framework for these markets
  • Challenges for harmonization in clinical trial legislation across the entire European Union member states
  •  Adaptive clinical trial design and adaptive licensing
  • Tamas L. Paal

    Tamas L. Paal, Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy
    View Bio

    14:20 Clinical trials in neurodegenerative disease

    Filippo Baldacci

    Filippo Baldacci, Medical Doctor, Researcher, University of Pisa
    View Bio

     

  • Clinical trials in Neurodegenerative diseases: A zoom on Alzheimer and Parkinson’s disease
  •  Patient selection and management
  • Patient care and perspectives
  •  Challenges and ongoing research developments
  • 15:00 Afternoon Tea

    15:30 Bayesian approaches in practice: Examples from early phase Oncology trials

    Simon Wandel

    Simon Wandel, Expert Statistical Methodologist, Novartis Pharmaceuticals
    View Bio

     

    • Prior derivation the (robust) meta-analytic-predictive approach
    • Using historical control data in phase II
    • Tailored multi-strata designs
    • Lessons learned from more than 100 Bayesian adaptive trials

    16:10 FOCUS4: Designing and delivering an Adaptive-Biomarker driven Multi Arm Mullti Stage (MAMS) cancer trial

    Kai-Keen Shiu

    Kai-Keen Shiu, FOCUS4 Trial Physician, MRC Clinical Trials Unit, UCL

     

  • Key barriers in translational research
  • Designing and Delivering an Adaptive-Biomarker driven trial to time and target
  • Advantages and Challenges of implementing novel methodologies 
  • Regulatory compliance and challenges from an academic perspective
  • 16:50 Panel Discussion: A rationale on adaptive designs in clinical trials

     

  • How are adaptive designs defined and best identified to improve clinical trials?
  •  How costly are continuous trial modifications and re-assessment in clinical trials? Does this hamper the adaptive nature of trial design?
  • What are the perceptions on real world data integration to increase flexibility and decision making in trials.
  • How significant are adaptive designs in each of the respective research areas on the panel?
  •  Compare and discuss biomarker development initiatives in the respective research areas on the panel: Trends and challenges.
  • Tamas L. Paal

    Tamas L. Paal, Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy
    View Bio

    Graham Clarke

    Graham Clarke, Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles
    View Bio

    Loic Darchy

    Loic Darchy, Head of Statistical Methodology Group , Sanofi Aventis
    View Bio

    Mohammad Al-Ubaydli

    Mohammad Al-Ubaydli, CEO, Patients Know Best
    View Bio

    Kai-Keen Shiu

    Kai-Keen Shiu, FOCUS4 Trial Physician, MRC Clinical Trials Unit, UCL

    17:30 Chairman's Closing Remarks and Close of Day One

    Tamas L. Paal

    Tamas L. Paal, Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy
    View Bio

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Robert Clay

    Robert Clay, Consultant, Highbury Regulatory Science; Chief Regulatory Officer, Kinapse; Board Director, TOPRA, Highbury Regulatory Science

    9:10 OPENING ADDRESS: Regulatory submissions across the international landscape

    Robert Clay

    Robert Clay, Consultant, Highbury Regulatory Science; Chief Regulatory Officer, Kinapse; Board Director, TOPRA, Highbury Regulatory Science

     

  •  Is there a global definition of “adaptive designs?”
  • Forecasting a global harmonization of regulatory requirements in adaptive designs
  • Major Parallels and discrepancies between the FDA, EMA and Japan’s PDMA that impact key areas of drug development such as decision making, bias control, pre-clinical studies and error control.
  • The processes of universal acceptance of emerging and unconventional adaptive designs.
  • The impact of regulatory time lags across international territories on drug development.
  • 9:50 Moving from adaptive license to MAPPs (Medicine Adaptive Pathways for Patients (MAPPs)

    Elin  Haf Davies

    Elin Haf Davies, Director, Enabling Research
    View Bio

    10:30 Morning Coffee

    11:00 Adaptive designs in neuroscience drug development

    Richard Wyse

    Richard Wyse, Director of Research and Development, The Cure Parkinsons Trust

     

  • Adaptive clinical developments in Parkinson’s disease
  • Clinical and latest technical collaborations across the PD community
  • Overcoming challenges
  • Applications of adaptive designs in relevant clinical areas of neuroscience
  • 11:40 Pharmacodynamics biomarkers in early phase oncology trials

    Sidath Katugampola

    Sidath Katugampola, Biomarker Development Scientist, Cancer Research UK

    12:20 Networking Lunch

    13:30 Novel Response-Adaptive Designs to enhance efficiency of clinical trials with time-to-event outcomes

    Alex Sverdlov

    Alex Sverdlov, Associate Director of Biostatistics , EMD Serono

     

  • Response-adaptive randomization designs for multi-armed survival trials
  • Covariate-adjusted response-adaptive randomization designs for survival trials with predictive biomarkers
  • Optimal dose finding designs for time-to-event clinical trials
  • Statistical software for implementing novel designs
  • 14:10 Group-sequential response-adaptive designs

    Steve  Coad

    Steve Coad, Reader in Statistics, Queen Mary, University of London
    View Bio

     

  • Constructing a group sequential design
  • Maintaining the overall type I error rate
  • Equal and unequal information levels
  • The elements of response-adaptive randomisation
  •  Incorporating covariate information

     

  • 14:50 Afternoon Tea

    15:20 Bandit models for the design of adaptive clinical trials in rare disease

    Sofia Villar

    Sofia Villar, Investigator Statistician , MRC Biostatistics Unit Hub for Trials Methodology Research

     

  • Multi –armed bandit models for the optimisation of clinical trials in rare diseases
  • Main challenges in multi-armed bandit models
  • Bayesian Bandit designs to optimise treatment selection in multiple-treatment studies
  • 16:00 Seamless adaptive designs: Methods for estimating treatment effect

    Peter Kimani

    Peter Kimani, Assistant Professor in Medical Statistics, Warwick Medical School

     

  • Design Strategy and motivation
  • Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes
  • Controlling the overall type I error rate
  • Case studies
  • Validating the end points and sample size estimation
  • 16:40 Chairman’s Closing Remarks and Close of Day Two

    Robert Clay

    Robert Clay, Consultant, Highbury Regulatory Science; Chief Regulatory Officer, Kinapse; Board Director, TOPRA, Highbury Regulatory Science

    +

    FEATURED SPEAKERS

    Alex Sverdlov

    Alex Sverdlov

    Associate Director of Biostatistics , EMD Serono
    Graham Clarke

    Graham Clarke

    Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles
    Robert Clay

    Robert Clay

    Consultant, Highbury Regulatory Science; Chief Regulatory Officer, Kinapse; Board Director, TOPRA, Highbury Regulatory Science
    Simon Wandel

    Simon Wandel

    Expert Statistical Methodologist, Novartis Pharmaceuticals
    Sophie Carr

    Sophie Carr

    MD and Principal Analyst, Bays Consulting Ltd
    Tamas L. Paal

    Tamas L. Paal

    Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy

    Alex Sverdlov

    Associate Director of Biostatistics , EMD Serono
    Alex Sverdlov

    Elin Haf Davies

    Director, Enabling Research
    Elin  Haf Davies

    Elin Haf Davies PhD – biography

    Elin Haf Davies began her career as a Paediatric Nurse at Great Ormond Street Hospital before going on to gain a PhD from University College London.
    After eight years of clinical experience Elin moved to research and spent six years managing clinical and academic drug trials, in metabolic, neurology, endocrinology and pain. Her PhD focused on the development of age-appropriate and disease specific biomarkers and clinical endpoints in neurometabolic.
    In 2007 Elin moved to work at the European Medicine Agency Paediatric Team where, amongst other projects she evaluated over a 100 Paediatric Investigation Plans, working closely with Scientific Advice and the Orphan team. After nearly six years there Elin now works independently Empowering Children | Enabling Research.
    In her free time Elin has a passion for extreme adventure to raise money for charities close to her heart. In 2007-2008 she rowed across the Atlantic Ocean, raising £190,000 for metabolic research at Great Ormond Street Hospital. Money that funded a PhD project that identified the value of Vitamin B6 for managing neonatal seizures.
    www.elinhafdavies.co.uk
     

    Emilie Gerard

    Biostatistician provider, Hays Life Sciences
    Emilie Gerard

    Filippo Baldacci

    Medical Doctor, Researcher, University of Pisa
    Filippo Baldacci

    Dr. Fillipo Baldacci, MD is a Neurologist Physician at “Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Italy”.

    He is the author and coauthor of 38 scientific publications (34 indexed in Pubmed), with experience in GCP acquired from 7 years of dedicated training. He  is also an experienced
    sub Investigator in 8 clinical trials, investigating movement disorders.
     

     

     

    Graham Clarke

    Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles
    Graham Clarke

    Dr. Graham Clarke PhD
     

    Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles Ltd
     

    Dr. Clarke joined Quintiles Drug Research Unit, London in August 2008 as Therapeutic Area Head of Respiratory. He responsible for developing patient strategy, biomarker development initiatives across the Allergy and Respiratory TA, reaching out across the Quintiles business to develop an integrated approach to drug development; including patient recruitment strategy, protocol design and optimizing biomarker read-outs. After gaining initial training as a clinical physiologist at the Royal Brompton Hospital, Dr. Clarke has worked across the industry spectrum in a variety of respiratory clinical research environments. He completed a PhD in respiratory pharmacology and physiology with focus on airway and vascular hyper-responsiveness in asthma at King's College, London, with particular focus on inhaled models of inflammation including LPS and Allergen in 2006. His current focus is challenge models of inflammation, airway biomarker identification and inhaler generics/inhaler characterisation studies in broncho-protection and broncho-dilation bioequivalence programmes He has acted as a consultant in respiratory clinical trial set-up, teaching, and presenting at an international level. He is the former editor of the respiratory physiology journal, Inspire, and holds an honorary contract at Imperial College London as a senior research fellow in the department of cardiothoracic pharmacology, National Heart & Lung Institute, where he contributes to the research and medical degree teaching program.
     

    Kai-Keen Shiu

    FOCUS4 Trial Physician, MRC Clinical Trials Unit, UCL
    Kai-Keen Shiu

    Loic Darchy

    Head of Statistical Methodology Group , Sanofi Aventis
    Loic Darchy

    Loïc has been working as Head of Statistical Methodology Group at Sanofi R&D for more than 5 years. He was previously in charge of the Internal Medicine Statistical Group for about 10 years at Sanofi too. Before joining Sanofi he worked for various pharmaceutical companies in multiple therapeutic areas such as immunology, inflammation diseases, oncology, cardiology and antibiotics. His favorite research areas are adaptive designs including biomarker-based designs, design and analysis of dose-finding studies, multiplicity issues, Bayesian statistics and data learning techniques.

    Mohammad Al-Ubaydli

    CEO, Patients Know Best
    Mohammad Al-Ubaydli

    Mohammad is founder and CEO of Patients Know Best and has over 15 years of experience in medical software. He trained as a physician at the University of Cambridge; worked as a staff scientist at the National Institutes of Health; and was a management consultant to US hospitals at The Advisory Board Company. He is the author of seven books, including Personal health records: A guide for clinicians and Streamlining Hospital-Patient Communication: Developing High Impact Patient Portals. He is also an honourary senior research associate at UCL medical school for his research on patient-controlled medical records. In 2012 he was elected an Ashoka Fellow as a social entrepreneur for the contributions he has made to patient care.

    Peter Kimani

    Assistant Professor in Medical Statistics, Warwick Medical School
    Peter Kimani

    Richard Wyse

    Director of Research and Development, The Cure Parkinsons Trust
    Richard Wyse

    Robert Clay

    Consultant, Highbury Regulatory Science; Chief Regulatory Officer, Kinapse; Board Director, TOPRA, Highbury Regulatory Science
    Robert Clay

    Sidath Katugampola

    Biomarker Development Scientist, Cancer Research UK
    Sidath Katugampola

    Simon Wandel

    Expert Statistical Methodologist, Novartis Pharmaceuticals
    Simon Wandel

    Simon Wandel holds a master in Statistics and a PhD in Medical Statistics/Epidemiology (both from University of Bern). In 2010, he joined the Early Clinical Biostatistics Group at Novartis Oncology as statistician, where he held roles with increasing responsibility (lead statistician, group manager). In 2014, he joined Novartis Oncology’s Statistical Methodology Group as Expert Statistical Methodologist. Simon Wandel has been involved in the design / analysis of numerous fully Bayesian phase I/II trials, for several of which he had close interactions with regulatory agencies. His main interest is in the use of historical and concurrent data in actual clinical trials.

    Sofia Villar

    Investigator Statistician , MRC Biostatistics Unit Hub for Trials Methodology Research
    Sofia Villar

    Sophie Carr

    MD and Principal Analyst, Bays Consulting Ltd
    Sophie Carr

    Steve Coad

    Reader in Statistics, Queen Mary, University of London
    Steve  Coad

    Steve Coad is a Reader in Statistics at Queen Mary, University of London, where he has worked since 2005, having previously held appointments at the Universities of Sussex, Michigan and Newcastle upon Tyne. He obtained his DPhil from the University of Oxford. He is currently an Associate Editor for Sequential Analysis and Statistical Methodology, and has been a Chartered Statistician since 1993 and a Chartered Mathematician since 1998. His research interests are mainly in the area of sequential design and analysis, with particular emphasis on estimation problems.

    Tamas L. Paal

    Professor Emeritus and Regulatory Adviser, University of Szeged, Hungary and National Institute of Pharmacy
    Tamas L. Paal


    Tamás L. Paál, having spent 11 years in the Hungarian pharmaceutical industry was Director-General of the National Institute of Pharmacy, the Hungarian drug regulatory agency from 1984 until his retirement in 2008. He is now contracted external advisor to the Agency.
    He has been promoted University professor in 1984, worked for the Postgraduate Medical University then the Semmelweis University, Budapest. He was also invited to estab-lish the Institute of Drug Regulatory Affairs in the Faculty of Pharmacy, University of Szeged (Szeged, Hungary).
    He is member of The Organisation of Professionals in Regulatory Affairs, the Europe-an Forum of Good Clinical Practice and the European Academy of Sciences and Arts.
     

    Official Media Partner

    Supporters

    Interview with Graham Clarke, Senior Director, Head of Respiratory & Inflammation Early Clinical Development, Quintiles

    Download

    Adaptive Designs Speaker Interview for Loic Darchy

    Download

    Interview with Alex Sverdlov, Associate Director of Biostatistics, EMD Serono

    Download

    Media Partners


    Clinical Investigation

    Official Media Partner
    http://www.future-science.com/loi/cli

    Clinical Investigation reflects the interdisciplinary nature of clinical research, and is designed for clinicians, researchers and policy/decision makers. The journal provides expert analysis of ongoing Phase I–IV trials and perspectives on how future trials should be run based on methodological, ethical and policy considerations. Each issue of the journal provides a robust and forward-looking view of the field for those involved in all stages of clinical research.

    Media Partners


    The Pharma Letter

    Supporters
    http://www.thepharmaletter.com/

    The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field.


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    One Nucleus

    Supporters
    http://www.onenucleus.com

    Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
    Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


    LabRoots

    Supporters
    http://www.labroots.com/

    LabRoots is a free, social networking site that enables scientists, engineers, and other technical professionals to connect, collaborate with, and learn from each other. LabRoots fosters world-wide scientific communication and incorporates the newest social networking technologies. LabRoots allows scientists to connect with each other as they describe their research interests on a myriad of unique features and tools, discovering meaningful collaborations across geographic boundaries and fields of expertise.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Pharmaceutical Online

    Supporters
    http://www.pharmaceuticalonline.com

    The premier sourcing site for the pharmaceutical manufacturing industry – find industry information on critical environment, particle sizing, pharma process control, pharma material handling, tablet production, pharma sterilizing, pharma cleaning, pharma filtration, pharma packaging, pharma inspection, & much more. Use our supplier directory, product showcase, and offline search service to expedite your discovery of new products and services.


    Contract Biotechnology

    Supporters
    http://www.contract-biotechnology.com

    Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. We are an online R&D matching tool that connects Scientifics and organizations involved in discovery, development and delivery of new healthcare products with service and products providers worldwide. Life science information technology is undergoing a revolution. Part of that revolution involves new, unexplored business models, open innovation, open data and collaboration. If you have a project or idea that you would like to propose, develop or run, we can help. A New Collaboration Network Model for Discovery Research and Development • Effective Platform: the 95% • 5.000 registered users // > 15.000 Newsletter subscribers • Geographical background: 45,5% Europe / 37,5% North America / 16,5% Asia / 0,5% ROW • Professional background: Outsourcing Manager, Project Manager, CEO, Business Developer, CSO, Account Manager, Sales & Marketing People, Scientists, R&D. For further information, please visit our website www.contract-biotechnology.com


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Farmavita

    Supporters
    http://www.farmavita.net/

    Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
    Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


    Lab Bulletin

    Supporters
    http://www.labbulletin.com

    Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information. Lab Bulletin also publishes four free monthly E-Newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. We have dedicated E-Newsletters for Chromatography and Spectroscopy, Microscopy and Image Analysis, weekly Industry News updates and our monthly Lab Bulletin E-Newsletter sent out to over 29,000 readers worldwide. To request your free copy click here


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


    Bioportfolio Limited

    Supporters
    http://www.bioportfolio.com

    BioPortfolio.com is a leading news, information and knowledge resource covering the global life science industries impacted by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources


    PharmCast

    Supporters
    http://www.PharmCast.com

    www.PharmCast.com is the world leading website designed specifically for pharmaceutical, clinical and biotechnology professionals. www.PharmCast.com brings up-to-date information on pharmaceutical patents, FDA, news, jobs and Buyer's Guide to our visitors. It was created and is maintained by pharmaceutical and biotechnology professionals. Visit www.PharmCast.com and discover for yourself why it is so popular among professionals.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    Cutting Edge

    Supporters
    http://www.cuttingedgeinfo.com

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Labhoo

    Supporters
    http://www.labhoo.com



    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.

    Marriott Regents Park

    128 King Henry's Road
    London NW3 3ST
    United Kingdom

    Marriott Regents Park

    This 4 star north London hotel in zone 2 is the perfect destination for the astute business traveler as well as the leisure guest that knows how convenient north London hotels are, as a base from which to explore the city .Bond Street is just 3 stops from Swiss Cottage underground station on the Jubilee Line, so you can be shopping, exploring the sights and taking in one of London’s world-renowned West End shows in less than 15 minutes when you stay at this hotel near central London. At the same time, the hive of activity that is Camden Town, the chic shops, cafes and restaurants of Primrose Hill and ZSL’s London Zoo in Regents Park are all just a short walk from this hotel in north London.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.